- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00441506
Effects of Daily Interruption of Sedatives in Critically Ill Children
Critically ill children are often sedated in order to relieve them from anxiety and discomfort, and to facilitate their care. There is little information on the effects of prolonged and continuous use of sedatives and analgesic agents in critically ill children. In adult intensive care unit (ICU) patients, daily interruption of sedative infusions accelerates recovery resulting in a reduction in the average duration of mechanical ventilation of 2.4 days as well as a reduction in average ICU length of stay of 3.5 days. These results were achieved without an increased rate of adverse events potentially linked to less sedation and associated with a reduction of common complications of critical illness and without negative psychological effects.
It is unknown whether these results can be extrapolated to critically ill children. Moreover, the possible risk of complications associated with less sedation, such as accidental self-extubation, is probably higher in children. Also, the need for intermittent bolus administrations in children treated with intermittent sedation could nullify the reduction in the use of sedatives.
It is unknown if daily interruption of sedatives is feasible in critically ill children. The researchers studied the effects of daily interruption of sedatives in critically ill children on the total amount of sedatives used and risks of complications.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Gelderland
-
Nijmegen, Gelderland, Holland, 6500HB
- Radboud University Nijmegen Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Intubated and mechanically ventilated for > 24 hours
- Expect further mechanical ventilation for > 48 hours
- Receiving midazolam and morphine for sedation
- Written informed consent given by parents
Exclusion Criteria:
- Inclusion in another trial
- Transfer from an outside institution where sedatives had been administered
- Neuromuscular blockers
- Metabolic disease
- Neuromuscular disease
- Encephalopathy
- Epilepsy
- Pulmonary hypertension
- Neurotrauma
- Raised intracranial pressure
- Life expectancy less than a month/infaust prognosis
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
amount of (near) incidents
Tidsramme: Until extubation or 28 days
|
Until extubation or 28 days
|
|
total amount of sedatives administered
Tidsramme: Until extubation or 28 days
|
Until extubation or 28 days
|
|
time to wake up (after sedation is stopped), comfort scale
Tidsramme: Until extubation or 28 days
|
Until extubation or 28 days
|
|
BIS monitoring
Tidsramme: Until extubation or 28 days
|
Until extubation or 28 days
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
time on ventilator
Tidsramme: Until extubation or 28 days
|
Until extubation or 28 days
|
|
LOS on ICU
Tidsramme: Until extubation or 28 days
|
Until extubation or 28 days
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studieleder: Peter Pickkers, MD, PhD, Radboud University Medical Center
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PP04
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .